Allspring Global Investments Holdings, LLC Inhibrx, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.2 Billion
Q1 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	SELL	$20.18 - $33.33 $100 - $166	-5 Reduced 2.45%	199 $0
Q3 2022 Oct 26, 2022	SELL	$11.58 - $24.73 $2,188 - $4,673	-189 Reduced 48.09%	204 $3,000
Q2 2022 Jul 25, 2022	SELL	$8.52 - $25.26 $32,077 - $95,103	-3,765 Reduced 90.55%	393 $4,000
Q1 2022 May 02, 2022	BUY	$19.89 - $43.18 $12,152 - $26,382	611 Added 17.23%	4,158 $92,000
Q4 2021 Jan 28, 2022	BUY	$26.75 - $46.02 $94,882 - $163,232	3,547 New	3,547 $154,000

Others Institutions Holding INBX

# of Institutions

132

Shares Held

35.5M

Call Options Held

64.8K

Put Options Held

91.3K

View Full List

About Inhibrx, Inc.

Ticker INBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,057,700
Market Cap $553M
Description
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...

More about INBX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account